Cargando…

A novel gene signature predicts chemoradiotherapy efficacy and tumor immunity in high‐grade glioma

Detalles Bibliográficos
Autores principales:	Xu, Shengchao, Tang, Lu, Dai, Gan, Luo, Chengke, Liu, Zhixiong
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2020
Materias:	Letter to Editor
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7507345/ https://www.ncbi.nlm.nih.gov/pubmed/32997418 http://dx.doi.org/10.1002/ctm2.170

Ejemplares similares

Immune-related genes with APA in microenvironment indicate risk stratification and clinical prognosis in grade II/III gliomas
por: Xu, Shengchao, et al.
Publicado: (2021)

Expression of m6A Regulators Correlated With Immune Microenvironment Predicts Therapeutic Efficacy and Prognosis in Gliomas
por: Xu, Shengchao, et al.
Publicado: (2020)

Hypoxia-Related lncRNA Correlates With Prognosis and Immune Microenvironment in Lower-Grade Glioma
por: Xu, Shengchao, et al.
Publicado: (2021)

A Novel Mice Model for Studying the Efficacy and IRAEs of Anti-CTLA4 Targeted Immunotherapy
por: Xu, Shengchao, et al.
Publicado: (2021)

Downregulation of CyclophilinA/CD147 Axis Induces Cell Apoptosis and Inhibits Glioma Aggressiveness
por: Xu, Shengchao, et al.
Publicado: (2020)

Immune Infiltration-Related Signature Predicts Risk Stratification and Immunotherapy Efficacy in Grade II and III Gliomas
por: Luo, Cong, et al.
Publicado: (2021)

Whole transcriptome and proteome analyses identify potential targets and mechanisms underlying tumor treating fields against glioblastoma
por: Xu, Shengchao, et al.
Publicado: (2022)

Correction: Whole transcriptome and proteome analyses identify potential targets and mechanisms underlying tumor treating fields against glioblastoma
por: Xu, Shengchao, et al.
Publicado: (2022)

Bioinformatic Analyses Identify a Prognostic Autophagy-Related Long Non-coding RNA Signature Associated With Immune Microenvironment in Diffuse Gliomas
por: Xu, Shengchao, et al.
Publicado: (2021)

CTLA-4 correlates with immune and clinical characteristics of glioma
por: Liu, Fangkun, et al.
Publicado: (2020)

A Nanoparticle-Conjugated Anti-TBK1 siRNA Induces Autophagy-Related Apoptosis and Enhances cGAS-STING Pathway in GBM Cells
por: Xu, Shengchao, et al.
Publicado: (2021)

circMMD reduction following tumor treating fields inhibits glioblastoma progression through FUBP1/FIR/DVL1 and miR-15b-5p/FZD6 signaling
por: Xu, Shengchao, et al.
Publicado: (2023)

Pediatric high-grade glioma resources from the Children’s Brain Tumor Tissue Consortium
por: Ijaz, Heba, et al.
Publicado: (2020)

CD74 Correlated With Malignancies and Immune Microenvironment in Gliomas
por: Xu, Shengchao, et al.
Publicado: (2021)

Integrated analysis identified CAPG as a prognosis factor correlated with immune infiltrates in lower‐grade glioma
por: Wei, Jinrui, et al.
Publicado: (2020)

Comment on “Intraoperative Contrast Enhanced Ultrasound Evaluates the Grade of Glioma”
por: Mahalangikar, Raman, et al.
Publicado: (2017)

Heme Oxygenase-1 Predicts Risk Stratification and Immunotherapy Efficacy in Lower Grade Gliomas
por: Ye, Wenrui, et al.
Publicado: (2021)

Pediatric high-grade glioma MYCN is frequently associated with Li-Fraumeni syndrome
por: Guerrini-Rousseau, Léa, et al.
Publicado: (2023)

An Immune-Related Signature for Predicting the Prognosis of Lower-Grade Gliomas
por: Zhang, Hongbo, et al.
Publicado: (2020)

Microbiota in cancer chemoradiotherapy resistance
por: He, Yan, et al.
Publicado: (2020)

Intraoperative magnetic resonance imaging for high grade glioma resection: Evidence-based or wishful thinking?
por: Kubben, Pieter L., et al.
Publicado: (2013)

Comment on “Simulating Radiotherapy Effect in High-Grade Glioma by Using Diffusive Modeling and Brain Atlases”
por: Borasi, Giovanni, et al.
Publicado: (2015)

Case report of chemoradiotherapy combined with immunotherapy for liver metastasis and lymph node metastases in the head of the pancreas of nasopharyngeal carcinoma
por: Zhang, Jingtong, et al.
Publicado: (2022)

Novel Immune-Related Gene Signature for Risk Stratification and Prognosis of Survival in Lower-Grade Glioma
por: Zhang, Mingwei, et al.
Publicado: (2020)

Immune Infiltrating Cells-Derived Risk Signature Based on Large-scale Analysis Defines Immune Landscape and Predicts Immunotherapy Responses in Glioma Tumor Microenvironment
por: Zhang, Nan, et al.
Publicado: (2021)

Unsectable cholangiocarcinoma: Additional therapy to chemoradiotherapy
por: Chaiyasit, Kamon, et al.
Publicado: (2013)

Immune Characteristics of LYN in Tumor Microenvironment of Gliomas
por: Jiang, Chonghua, et al.
Publicado: (2022)

Activating BRAF G469A Missense Mutation in a Pediatric Patient With High-Grade Glioma
por: Kronish, Adam, et al.
Publicado: (2021)

Spontaneous regression of tumor in a girl with optic pathway glioma with diencephalic syndrome
por: Luo, Rutao, et al.
Publicado: (2023)

Reply: Adjuvant chemoradiotherapy is no alternative to intensified neoadjuvant chemoradiotherapy for local and systemic control in patients with locally advanced rectal cancer
por: Klautke, G, et al.
Publicado: (2006)

Immunotherapy in gliomas: Are we reckoning without the innate immunity?
por: Vismara, Marco Flavio Michele, et al.
Publicado: (2019)

Chemoradiotherapy Alters Protein Expression in Glioblastoma Multiforme
por: Hwang, Mina, et al.
Publicado: (2020)

Development and validation of an immune-related gene signature for predicting the radiosensitivity of lower-grade gliomas
por: Yan, Derui, et al.
Publicado: (2022)

An Immune-Related Gene Signature for Predicting Neoadjuvant Chemoradiotherapy Efficacy in Rectal Carcinoma
por: Qian, Liwen, et al.
Publicado: (2022)

Application of PET-MRI in pseudo progression versus true progression in High Grade Gliomas: A new avenue!
por: Tiwari, Vivek, et al.
Publicado: (2014)

The molecular feature of macrophages in tumor immune microenvironment of glioma patients
por: Zhang, Hao, et al.
Publicado: (2021)

Recurrence patterns in patients with high-grade glioma following temozolomide-based chemoradiotherapy
por: Zhou, Xiaofeng, et al.
Publicado: (2016)

Receptor tyrosine kinase expression in high-grade gliomas before and after chemoradiotherapy
por: Wang, Kuanyu, et al.
Publicado: (2019)

A Novel Four-Gene Signature Associated With Immune Checkpoint for Predicting Prognosis in Lower-Grade Glioma
por: Xiao, Youchao, et al.
Publicado: (2020)

A novel tailored immune gene pairs signature for overall survival prediction in lower-grade gliomas
por: Pan, Xuyan, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_pcs5ha8ka6ckjna4v9935qiidv